NEUCA S.A. (WSE:NEU)

Market Cap	3.04B
Revenue (ttm)	12.61B
Net Income (ttm)	154.24M
Shares Out	4.47M
EPS (ttm)	34.01
PE Ratio	19.99
Forward PE	12.51
Dividend	14.50 (2.16%)
Ex-Dividend Date	Jun 12, 2024

Volume	1,006
Average Volume	2,425
Open	672.00
Previous Close	671.00
Day's Range	672.00 - 690.00
52-Week Range	636.00 - 969.00
Beta	0.65
RSI	29.97
Earnings Date	Mar 28, 2025

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,633
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.